Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001641172-25-024175
Filing Date
2025-08-14
Accepted
2025-08-14 17:12:55
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B3 form424b3.htm 424B3 682873
2 GRAPHIC form424b3_001.jpg GRAPHIC 3574
3 GRAPHIC form10-q_001.jpg GRAPHIC 6470
  Complete submission text file 0001641172-25-024175.txt   698138
Mailing Address 15 INDEPENDENCE BOULEVARD, SUITE #210 WARREN NJ 07059
Business Address 15 INDEPENDENCE BOULEVARD, SUITE #210 WARREN NJ 07059 646-807-8832
Tevogen Bio Holdings Inc. (Filer) CIK: 0001860871 (see all company filings)

EIN.: 981597194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-280414 | Film No.: 251220939
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)